1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

1276.HK
Jiangsu Hengrui Pharmaceuticals Co.,LtdHK flagHong Kong Stock Exchange
55.15
HKD
+2.60
- -
366.04BMarket Cap

Total Valuation

Jiangsu Hengrui Pharmaceuticals Co.,Ltd carries a market capitalization of 366.04B, placing it among publicly traded companies globally. Its enterprise value stands at 271.12B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap366.04B
Enterprise Value271.12B

Share Statistics

Jiangsu Hengrui Pharmaceuticals Co.,Ltd currently has 6.64B shares outstanding.

Shares Outstanding6.64B
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Jiangsu Hengrui Pharmaceuticals Co.,Ltd trades at a trailing price-to-earnings ratio of 41.70. The price-to-sales ratio is 10.17, and the price-to-book ratio stands at 7.02.

PE Ratio41.70
PS Ratio10.17
PB Ratio7.02
P/TBV Ratio5.76
P/FCF Ratio134.99
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Jiangsu Hengrui Pharmaceuticals Co.,Ltd trades at an EV/EBITDA multiple of 33.90 and an EV/FCF ratio of 118.70. The EV/Sales ratio of 8.99 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 33.90 provides insight into valuation relative to core operating earnings.

EV / Sales8.99
EV / EBITDA33.90
EV / EBIT33.90
EV / FCF118.70

Financial Position

Jiangsu Hengrui Pharmaceuticals Co.,Ltd maintains a current ratio of 13.49, meaning it holds 13.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.15, indicating conservative leverage, while an interest coverage ratio of 575.08 demonstrates strong ability to service its debt obligations.

Current Ratio13.49
Quick Ratio10.46
Debt / Equity0.15
Debt / EBITDA0.01
Interest Coverage575.08

Financial Efficiency

Jiangsu Hengrui Pharmaceuticals Co.,Ltd posts a return on equity of 18.16 and a return on invested capital of 13.51.

Return on Equity (ROE)18.16
Return on Assets (ROA)13.24
Return on Invested Capital (ROIC)13.51
Return on Capital Employed (ROCE)17.87
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.69

Taxes

Over the trailing twelve months, Jiangsu Hengrui Pharmaceuticals Co.,Ltd has paid 1.11B in income taxes, reflecting an effective tax rate of 13.05.

Income Tax1.11B
Effective Tax Rate13.05

Stock Price Statistics

Jiangsu Hengrui Pharmaceuticals Co.,Ltd's stock has declined approximately -4.58478% over the past 52 weeks. The 50-day moving average sits at 63.30, while the 200-day moving average is 71.39.

Beta (5Y)N/A
52-Week Price Change-4.58478%
50-Day Moving Average63.30
200-Day Moving Average71.39
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Jiangsu Hengrui Pharmaceuticals Co.,Ltd generated 30.15B in revenue and converted that into 7.35B in net income, yielding earnings per share of 1.18. EBITDA reached 8.00B, while operating income came in at 8.00B.

Revenue30.15B
Gross Profit26.06B
Operating Income8.00B
Pretax Income8.47B
Net Income7.35B
EBITDA8.00B
EBIT8.00B
Earnings Per Share (EPS)1.18

Balance Sheet

Jiangsu Hengrui Pharmaceuticals Co.,Ltd holds 36.23B in cash and equivalents against 91.43M in total debt, resulting in a net debt position of -36.12B. Total book value stands at 43.68B, with working capital of 43.30B providing operational flexibility.

Cash & Cash Equivalents36.23B
Total Debt91.43M
Net Debt-36.12B
Equity (Book Value)43.68B
Book Value Per Share6.99
Working Capital43.30B

Cash Flow

After subtracting -2.27B in capital expenditures, free cash flow totaled -2.27B - equivalent to -0.36 per share.

Operating Cash FlowN/A
Capital Expenditures-2.27B
Free Cash Flow-2.27B
FCF Per Share-0.36

Margins

Jiangsu Hengrui Pharmaceuticals Co.,Ltd operates with a gross margin of 86.43, reflecting its pricing power and cost economics. The operating margin of 26.53 and net profit margin of 24.40 provide insight into operational efficiency.

Gross Margin86.43
Operating Margin26.53
Pretax Margin28.09
Profit Margin24.40
EBITDA Margin26.53

Dividends & Yields

The company's payout ratio of 17.28 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.20
Dividend YieldN/A
Payout Ratio17.28
Shareholder Yield-2.16
FCF Yield0.74

Scores

Jiangsu Hengrui Pharmaceuticals Co.,Ltd posts an Altman Z-Score of 50.43, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score50.43